Study to Evaluate MEDI-534 in Healthy Adults

Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults

NCT00192465 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557

NCT00578682 ·Status: COMPLETED ·Phase: PHASE1

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373472 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

NCT02298179 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

NCT04144348 ·Status: COMPLETED ·Phase: PHASE1

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

NCT06573281 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

NCT06237296 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

NCT01544361 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

NCT01756482 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety of MEDI7836 in Healthy Adults.

NCT02388347 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

NCT02151110 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

NCT04798001 ·Status: UNKNOWN ·Phase: PHASE1

A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults

NCT05903118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

NCT05639894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

NCT05439824 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

NCT02115815 ·Status: COMPLETED ·Phase: PHASE1

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

NCT01475305 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine

NCT01255410 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children

NCT00767416 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

NCT06113744 ·Status: RECRUITING ·Phase: PHASE1

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

NCT05281263 ·Status: COMPLETED ·Phase: PHASE1

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above

NCT05374954 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants

NCT05712460 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

NCT05972993 ·Status: COMPLETED ·Phase: PHASE1